Derzi, Mazin
12  Ergebnisse:
Personensuche X
?
1

Microphysiological systems in early stage drug development:..:

Kopec, Anna K. ; Yokokawa, Ryuji ; Khan, Nasir...
The Journal of Toxicological Sciences.  46 (2021)  3 - p. 99-114 , 2021
 
?
2

Comparative nonclinical assessments of the biosimilar PF-06..:

Derzi, Mazin ; Shoieb, Ahmed M. ; Ripp, Sharon L....
Regulatory Toxicology and Pharmacology.  112 (2020)  - p. 104587 , 2020
 
?
3

Evaluation of Therapeutics for Severely Debilitating or Lif..:

Liu, Maggie ; Fields, F. Owen ; Prescott, Judith S....
Clinical Pharmacology & Therapeutics.  107 (2019)  3 - p. 514-520 , 2019
 
?
4

An Industry Perspective on the 2017 EMA Guideline on First‐..:

DeGeorge, Joseph ; Robertson, Sarah ; Butler, Lynne...
Clinical Pharmacology & Therapeutics.  103 (2017)  4 - p. 566-569 , 2017
 
?
5

Industry Perspective on Biomarker Development and Qualifica..:

Gerlach, Cory V. ; Derzi, Mazin ; Ramaiah, Shashi K..
Clinical Pharmacology & Therapeutics.  103 (2017)  1 - p. 27-31 , 2017
 
?
6

Current nonclinical testing paradigms in support of safe cl..:

Butler, Lynne D. ; Guzzie-Peck, Peggy ; Hartke, James...
Regulatory Toxicology and Pharmacology.  87 (2017)  - p. S1-S15 , 2017
 
?
9

Corrigendum to ''An overview of the preclinical toxicity an..:

Owen, Keith ; Cross, David M. ; Derzi, Mazin..
Regulatory Toxicology and Pharmacology.  64 (2012)  3 - p. 490 , 2012
 
?
10

An overview of the preclinical toxicity and potential carci..:

Owen, Keith ; Cross, David M. ; Derzi, Mazin..
Regulatory Toxicology and Pharmacology.  64 (2012)  1 - p. 95-103 , 2012
 
?
11

Evaluation of sitaxentan (Thelin®) toxicity in juvenile rat..:

Cross, David M. ; Derzi, Mazin ; Horsley, Elizabeth..
Regulatory Toxicology and Pharmacology.  64 (2012)  1 - p. 43-50 , 2012
 
1-12